Land: Australia
Språk: engelsk
Kilde: Department of Health (Therapeutic Goods Administration)
hydroxocobalamin chloride, Quantity: 1 mg/mL
Aspen Pharmacare Australia Pty Ltd
Hydroxocobalamin chloride
Injection, solution
Excipient Ingredients: water for injections; sodium chloride
Intramuscular
3
Not scheduled. Not considered by committee
Prophylaxis and treatment of pernicious (Addisonian) anaemia and other macrocytic anaemias associated with vitaminB12 deficiency. Treatment of optic neuropathies such as tobacco amblyopia and Leber's optic atrophy.
Visual Identification: clear dark red solution; Container Type: Ampoule; Container Material: Glass Type I Coloured; Container Life Time: 2 Years; Container Temperature: Store below 25 degrees Celsius
Licence status A
2010-07-22
HYDROXO-B12 INJECTION _Hydroxocobalamin (hye-drox-oh-koe-BAL-a-min)_ CONSUMER MEDICINE INFORMATION (CMI) WHAT IS IN THIS LEAFLET This leaflet answers some common questions about HYDROXO-B12 Injection. It does not contain all the available information. It does not take the place of talking to your doctor or pharmacist. All medicines have risks and benefits. Your doctor or pharmacist has weighed the risks of you being given this medicine against the benefits they expect it will have for you. IF YOU HAVE ANY CONCERNS ABOUT BEING GIVEN IT, ASK YOUR DOCTOR OR PHARMACIST. KEEP THIS LEAFLET WITH THE MEDICINE. You may need to read it again. WHAT HYDROXO-B12 INJECTION IS USED FOR HYDROXO-B12 Injection contains hydroxocobalamin as the active ingredient which is a form of vitamin B12. It is used for the prevention and treatment of anaemias associated with vitamin B12 deficiency. It is also used to treat diseases of nerves in the eyes. ASK YOUR DOCTOR IF YOU HAVE ANY QUESTIONS ABOUT WHY HYDROXO- B12 INJECTION HAS BEEN PRESCRIBED FOR YOU. Your doctor may have prescribed this medicine for another reason. This medicine is not addictive. BEFORE YOU ARE GIVEN IT _WHEN YOU MUST NOT BE GIVEN_ _IT_ YOU MUST NOT BE GIVEN HYDROXO-B12 INJECTION IF YOU HAVE AN ALLERGY TO: • hydroxocobalamin • cobalt • any of the ingredients listed at the end of this leaflet. Symptoms of an allergic reaction may include shortness of breath, wheezing or difficulty breathing; swelling of the face, lips, tongue or other parts of the body; skin rash, itching or hives. YOU MUST NOT BE GIVEN IT TO TREAT MEGALOBLASTIC ANAEMIA OF PREGNANCY. This is a type of anaemia usually caused by the deficiency of another vitamin called folic acid. YOU MUST NOT BE GIVEN THIS MEDICINE AFTER THE EXPIRY DATE PRINTED ON THE PACK OR IF THE PACKAGING IS TORN OR SHOWS SIGNS OF TAMPERING. If it has expired or is damaged return it to your pharmacist for disposal. IF YOU ARE NOT SURE WHETHER YOU SHOULD BE GIVEN THIS MEDICINE, TALK TO YOUR DOCTOR. _BEFORE YOU ARE GIVEN IT_ TELL Y Les hele dokumentet
HYDROXO-B12 – Product Information Page 1 of 7 AUSTRALIAN PRODUCT INFORMATION - HYDROXO-B12 (HYDROXOCOBALAMIN CHLORIDE) 1. NAME OF MEDICINE Hydroxocobalamin chloride (vitamin B 12 ) 2. & 3. QUALITATIVE AND QUANTITATIVE COMPOSITION AND PHARMACEUTICAL FORM Hydroxocobalamin is a dark red, odourless crystalline powder or crystals. It is soluble in water and alcohol, sparingly soluble in methyl alcohol and practically insoluble in acetone, chloroform and ether. Hydroxocobalamin (as chloride) and hydroxocobalmin chloride 1.027 mg/mL equivalent to 1.0 mg/mL hydroxocobalmin. HYDROXO-B12 also contains sodium chloride 9.0 mg and hydrochloric acid for pH adjustment and water for injections. The pH of the solution is approximately 4.6. Solution for injection in ampoules, 1mg/mL (1000 microgram/mL) (clear dark red solution) in a pack of 3 ampoules. 4. CLINICAL PARTICULARS 4.1 THERAPEUTIC INDICATIONS Prophylaxis and treatment of pernicious (Addisonian) anaemia and other macrocytic anaemias associated with vitamin B 12 deficiency. Treatment of optic neuropathies such as tobacco amblyopia and Leber's optic atrophy. 4.2 DOSE AND METHOD OF ADMINISTRATION This product contains no antimicrobial agent. It is for single use in one patient only. Discard any residue. Hydroxo-B12 Injection is to be administered INTRAMUSCULARLY. The following dosage schemes are suitable for adults and children: ADDISONIAN PERNICIOUS ANAEMIA AND OTHER MACROCYTIC ANAEMIAS WITHOUT NEUROLOGICAL INVOLVEMENT. _ _ _INITIALLY._ 250 to 1,000 micrograms intramuscularly on alternate days for one to two weeks, then 250 micrograms weekly until the blood count is normal. _MAINTENANCE._ 1,000 micrograms every two or three months. ADDISONIAN PERNICIOUS ANAEMIA AND OTHER MACROCYTIC ANAEMIAS WITH NEUROLOGICAL INVOLVEMENT. _ _ _INITIALLY._ 1,000 micrograms on alternate days for one to two weeks. _MAINTENANCE._ 1,000 micrograms every two months. HYDROXO-B12 – Product Information Page 2 of 7 PROPHYLAXIS OF MACROCYTIC ANAEMIA ASSOCIATED WITH VITAMIN B12 DEFICIENCY RESULTING Les hele dokumentet